JFGIW
IGC icon

Johnson Financial Group Inc (Wisconsin)’s IGC Pharma IGC Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New – ﹤0.01% 888

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s IGC Position: Q1 2026 in Review

Johnson Financial Group Inc (Wisconsin) opened a new position in IGC Pharma (IGC) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #888 among its holdings.

35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Johnson Financial Group Inc (Wisconsin) held 1 share of IGC Pharma worth $1 as of Q1 2026.
  • IGC Pharma was a new Johnson Financial Group Inc (Wisconsin) position in Q1 2026.
  • IGC Pharma made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q1 2026, its #888 holding.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2026, filed 7 May 2026.